Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mereo BioPharma (MREO) Debt Ratio (2020 - 2022)

Mereo BioPharma (MREO) has disclosed Debt Ratio for 3 consecutive years, with 0.01 as the latest value for Q4 2022.

  • On a quarterly basis, Debt Ratio fell 94.48% to 0.01 in Q4 2022 year-over-year; TTM through Dec 2022 was 0.01, a N/A change, with the full-year FY2021 number at 0.11, down 55.63% from a year prior.
  • Debt Ratio was 0.01 for Q4 2022 at Mereo BioPharma, down from 0.11 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.26 in Q4 2020 to a low of 0.01 in Q4 2022.
  • A 3-year average of 0.13 and a median of 0.11 in 2021 define the central range for Debt Ratio.
  • Peak YoY movement for Debt Ratio: tumbled 55.63% in 2021, then plummeted 94.48% in 2022.
  • Mereo BioPharma's Debt Ratio stood at 0.26 in 2020, then crashed by 55.63% to 0.11 in 2021, then tumbled by 94.48% to 0.01 in 2022.
  • Per Business Quant, the three most recent readings for MREO's Debt Ratio are 0.01 (Q4 2022), 0.11 (Q4 2021), and 0.26 (Q4 2020).